Some studies have reported that FXR activity could inhibit the occurrence of HCC, suppressing BA reuptake to hepatocytes and hepatic inflammation, and directly increasing the expression of tumor‐suppressor genes (Huang et al. 2015; Ananthanarayanan et al. 2001). This evidence concerns the gene NR1H4 and neoplasm.